Medicine
Mercaptopurine 50 mg tablet
Mercaptopurine 50 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Store in a dry place.
Key facts
- Active ingredient (INN)
- Mercaptopurine
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 25 tablets, 250 tablets and 2 more
- Manufacturers
- Florida Pharmaceutical ProductsHikma PharmaceuticalsGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Store in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01BB02 Mercaptopurine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 February 2004
- Identifiers
- RxCUI 197931DailyMed set ID 4bae5ffb-a535-3fa0-e063-6294a90aa90a, e7309808-5ae8-4a55-90e3-3992ace0da62, c3b5b8b0-bc5c-4ce9-bbdc-febba60c2658NDC 51407-983, 71921-150, 0054-4581Application ANDA040528, NDA009053
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 tablet in 1 bottle | 71921-150-02 | Florida Pharmaceutical Products | 30 January 2026 |
| 250 tablet in 1 bottle | 71921-150-25 | Florida Pharmaceutical Products | 30 January 2026 |
| 25 tablet in 1 bottle, plastic | 0054-4581-11 | Hikma Pharmaceuticals | 13 February 2004 |
| 250 tablet in 1 bottle, plastic | 0054-4581-27 | Hikma Pharmaceuticals | 13 February 2004 |
| 250 tablet in 1 bottle, plastic | 51407-983-25 | Golden State Medical Supply | 19 January 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Mercaptopurine
Clinical summary
Mercaptopurine is a nucleoside metabolic inhibitor indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. It is available as oral suspension and tablets. MedsAcross supplies Mercaptopurine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MercaptopurineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mercaptopurine prescribing information (Florida Pharmaceutical Products) · U.S. National Library of Medicine, DailyMed
- Xaluprine (previously Mercaptopurine Nova Laboratories): European public assessment report (EPAR) · European Medicines Agency
Need Mercaptopurine 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.